Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (ptmc): a mono-institutional 12-year experience

Nuclear Medicine Communications

Volumn 25, Issue 6, 2004, Pages 547-552

  Pelizzo, Maria Rosa ^a   Boschin, Isabella Merante ^a   Toniato, Antonio ^a   Pagetta, Costantino ^b   Piotto, Andrea ^b   Bernante, Paolo ^a   Casara, Dario ^a   Pennelli, Gianmaria ^a   Rubello, Domenico ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Papillary thyroid microcarcinoma; Prognosis; Recurrence; Treatment

Indexed keywords

IODINE 131;

CANCER RECURRENCE; CANCER RISK; FOLLOW UP; HISTOPATHOLOGY; HUMAN; PAPILLARY CARCINOMA; PAPILLARY THYROID MICROCARCINOMA; REVIEW; THYROID CARCINOMA; THYROIDECTOMY;

ADOLESCENT; ADULT; AGED; CARCINOMA, PAPILLARY; CHILD; FEMALE; HUMANS; IODINE RADIOISOTOPES; ITALY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 2542631115     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000126625.17166.36     Document Type: Article

References (23)

1. Histologic typing of thyroid tumours. In: Hedinger C, Williams ED, Sobin LH, eds. International Histological Classification of Tumours, No. 11. Geneva: World Health Organization; 1988. 1-18.
2. Sampson RJ, Key CR, Buncher CR, Iijima S. Thyroid carcinoma in Hiroshima and Nagasaki: prevalence of thyroid carcinoma at autopsy. J Am Med Assoc 1969; 209:65-70.
3. Rossi RL, Cady B, Silverman ML, Wool MS, Horner TA. Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg 1986; 10:612-622.
4. Pelizzo MR, Piotto A, Rubello D, Casara D, Fassina A, Busnardo B. High prevalence of occult papillary thyroid carcinoma in a surgical series for benign thyroid disease. Tumori 1990; 76:255-257.
5. Baudin E, Travagli JP, Ropers J, Mancusi F, Bruno-Bossio G, Caillou B, et al. Microcarcinoma of the thyroid gland. The Gustave-Roussy Institute experience. Cancer 1998; 83:553-559.
6. Bramley MD, Harrison BJ. Papillary microcarcinoma of the thyroid gland. Br J Surg 1996; 83:1674-1683.
7. Kasai N, Sakamoto A. New subgrouping of small thyroid carcinomas. Cancer 1987; 60:1767-1770.
8. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994; 97:418-428.
9. Melliere D. Petits nodules thyroidiens et microcancers. Press Med 1995; 24:1552-1554.
10. Strate SM, Lee EL, Childers JH. Occult papillary carcinoma of the thyroid with distant metastases. Cancer 1984; 54:1093-1100.
11. Appetecchia M, Scarcello G, Pucci E, Procaccini A.Outcome after treatment of papillary thyroid microcarcinoma. J Exp Clin Cancer Res 2002; 21:159-164.
12. Harach MR, Fraussila KO, Wasenius VM. Occult papillary of the thyroid: a normal finding in Finland. A systematic autopsy study. Cancer 1985; 56:531-538.
13. Sanders LE, Rossi RL. Occult well differentiated thyroid carcinoma presenting as cervical node disease. World J Surg 1995; 19:642-646.
14. Hay ID, Grant CS, Van Heerden JA, Goellner JR, Eberson JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-years period. Surgery 1992; 112:1139-1147.
15. Yamamoto Y, Maeda T, Izumi K, Otzuka M. Occult papillary carcinoma of the thyroid: a study of 408 autopsy cases. Cancer 1990; 65:1173-1179.
16. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 2003; 88(4):1433-1441.
17. Casara D, Rubello D, Saladini G, Masurotto G, Girelli ME, Busnardo B, et al. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 1993; 34:1626-1631.
18. Casara D, Rubello D, Saladini G, De Besi P, Fassina A, Busnardo B. Differentiated thyroid carcinoma in the elderly. Aging 1992; 4:333-339.
19. Rubello D, Girelli ME, Casara D, Piccolo M, Perin A, Busnardo B. Usefulness of the combined antithyroglobulin and thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer. J Endocrinol Invest 1990; 13:737-742.
20. Rubello D, Casara D, Girelli ME, Piccolo M, Busnardo B. Clinical meaning of circulating antithyroglobulin antibodies in differentiated thyroid cancer: a prospective study. J Nucl Med 1992; 33:1478-1480.
21. Rubello D, Mazzarotto R, Casara D. The role of technetium-99-m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery. Eur J Nucl Med 2000; 27:431-440.
22. Evans HL. Encapsulated thyroid papillary neoplasms of the thyroid. A study of 14 cases followed for a minimum of 10 years. Am J Surg Pathol 1987; 11:592-597.
23. Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, et al. An observational trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003; 13:381-387.